Company Filing History:
2 out of 66 
2 out of 846 
Years Active: 2014-2017
Title: The Innovative Journey of Alessia Ligresti: Pioneering Phytocannabinoid Research
Introduction: Alessia Ligresti, an accomplished inventor based in Pozzuoli, Italy, has made significant contributions to the field of cancer treatment through her innovative research on phytocannabinoids. With two patents to her name, Ligresti stands out in the realm of medical sciences, particularly in developing therapies that aim to combat cancer effectively.
Latest Patents: Ligresti's most notable patents focus on the use of phytocannabinoids in the treatment of cancer. This groundbreaking invention relates to the application of phytocannabinoids, either in an isolated form or as a botanical drug substance (BDS), targeting specific types of cancers such as prostate, breast, and colon cancer. Her work demonstrates not only her commitment to advancing medical treatments but also her pioneering spirit in exploring alternative therapies.
Career Highlights: Throughout her career, Alessia Ligresti has collaborated with leading pharmaceutical companies, including GW Pharma Limited and Otsuka Pharmaceutical Company, Limited. Her tenure in these organizations has helped propel her research forward, allowing her to refine her inventions and bring her innovative ideas to fruition.
Collaborations: Ligresti's success is amplified by her collaborations with esteemed colleagues such as Daniela Parolaro and Paola Massi. Working alongside these talented individuals, Ligresti has fostered an environment of innovation and creativity, which has been crucial for the development of her patents and further research in the field.
Conclusion: With her focus on phytocannabinoids for cancer treatment, Alessia Ligresti is making strides that may redefine therapeutic approaches in oncology. Her work extends the possibilities of how phytocannabinoids can be utilized in medical treatments, marking her as a significant figure in the ongoing quest for effective cancer therapies. Ligresti's dedication to innovation continues to inspire future research and development in the pharmaceutical industry.